Differential Target Molecules for Toxicity Induced by Streptozotocin and Alloxan in Pancreatic Islets of Mice in Vitro

Experimental and Clinical Endocrinology and Diabetes

Volumn 112, Issue 1, 2004, Pages 29-37

  Gai, W ^a   Schott Ohly, P ^a   Schulte Im Walde, S ^a   Gleichmann, Helga ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Alloxan; Pancreatic islets; Streptozotocin; Target molecules

Indexed keywords

ALLOXAN; GLUCOKINASE; GLUCOSE TRANSPORTER 2; MESSENGER RNA; PROINSULIN; STREPTOZOCIN; THIOGLUCOSE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

ALLOXAN; ANIMALS; ARGININE; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 2; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; MONOSACCHARIDE TRANSPORT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STREPTOZOCIN;

EID: 1242340281     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815724     Document Type: Article

References (26)

1. Alonso S, Minty A, Bourlet X, Buckingham M. Comparison of three acting-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol 1986; 23: 11-22
2. Atkinson MA, MacLaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428-1436
3. Boquist L. A new hypothesis for alloxan diabetes. Acta Path Microbiol Scand Sect A 1980; 88: 202-209
4. Chomczynski P, Sacchi N. Singlestep method for RNA isolation by acid guanidin thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 126: 156-159
5. Crouch RK, Gandy SE, Kimsey G, Galbraith RA, Galbraith GM, Buse MG. The inhibition of islet superoxide dismutase by diabetogenic drugs. Diabetes 1981; 30: 235-241
6. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 2000; 43: 1528-1533
7. Elsner M, Tiedge M, Guldbakke B, Munday R, Lenzen S. Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan. Diabetologia 2002; 45: 1542-1549
8. Gille L, Schott-Ohly P, Friesen N, Schulte im Walde S, Udilova N, Nohl H, Gleichmann H. Generation of hydroxyl radicals mediated by streptozotocin in pancreatic islets of mice in vitro. Pharmacol Toxicol 2002; 90: 317-326
9. Gunnarsson R, Berne C, Hellerstrom C. Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide. Biochem J 1974; 140: 487-494
10. Klinkhammer C, Popowa P, Gleichmann H. Specific immunity to streptozotocin: cellular requirements for induction of lymphoproliferation. Diabetes 1988; 37: 74-80
11. Lenzen S, Panten U. Alloxan: history and mechanism of action. Diabetologia 1988; 31: 337-342
12. 2+ transport. Mol Cell Biochem 1992; 118: 141-151
13. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976; 193: 415-417
14. Malaisse-Lagae F, Sener A, Malaisse WJ. Contrasting modes of action of D-glucose and 3-O-methyl-D-glucose as protectors of the rat pancreatic β-cell against alloxan. Biochim Biophys Acta 1983; 762: 36-43
15. Murata M, Takahashi A, Saito I, Kawanishi S. Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin. Biochem Pharmacol 1999; 57: 881-887
16. Oberley LW. Free radicals and diabetes. Free Radic Biol Med 1988; 5: 113-124
17. Schnedl WJ, Ferber S, Johnson J, Newgard CB. STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells. Diabetes 1994; 43: 1326-1333
18. Schulte im Walde S, Dohle C, Schott-Ohly P, Gleichmann H. Molecular target structures in alloxan-induced diabetes in mice. Life Sci 2002; 71: 1681-1694
19. Sener A, Malaisse WJ. Resistance to alloxan of tumoral insulin-producing cells. FEBS 1985; 193: 150-152
20. 2 as mediator for DNA fragmentation. Diabetes 1991; 40: 1141-1145
21. Thorens B, Weir GC, Leahy JL, Lodish HF, Bonner-Weir S. Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats. Proc Natl Acad Sci USA 1990; 87: 6492-6496
22. Wang Z, Dohle C, Friemann J, Green BS, Gleichmann H. Prevention of high- and low-dose STZ-induced diabetes with D-glucose and 5-thio-D-glucose. Diabetes 1993; 42: 420-428
23. Wang Z, Gleichmann H. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 1998; 47: 50-56
24. Watson CJ, Demmer J. Procedures for cDNA cloning. In: Glover DM, Hames BB (eds). DNA Cloning 1 - Core Techniques. New York: Oxford University Press, 1995: 83-119
25. Zhang H, Brunk U. Alloxan cytotoxicity is highly potentiated by plasma membrane and lysosomal-associated iron - a study on a model system of cultured J-774 cells. Diabetologia 1993; 36: 707-715
26. Zimny S, Gogolin F, Abel J, Gleichmann H. Metallothionein in isolated pancreatic islets of mice: induction by zinc and streptozotocin, a naturally occurring diabetogen. Arch Toxicol 1993; 67: 61-65